How many insider trades does FilingIQ track for AYTU?

FilingIQ tracks 213 Form 4 insider transactions for AYTU (AYTU BIOPHARMA, INC), covering filings from Nov 11, 2015 onwards. 8 of those were filed in the last 90 days.

Are AYTU insiders net buyers or net sellers?

Across the full Form 4 history for AYTU, 26 transactions (12%) were open-market purchases and 8 (4%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does AYTU insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is AYTU in?

AYTU BIOPHARMA, INC (AYTU) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $23.61M.

AYTU insider trading

NasdaqCM Healthcare

AYTU BIOPHARMA, INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

213

Last 90 days

Buys / sells

12% / 4%

Market cap

$23.61M

About AYTU BIOPHARMA, INC

Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old; and Metadate CD, a central nervous system stimulant indicated for the treatment of ADHD. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.

Company website: aytubio.com

AYTU insider activity at a glance

FilingIQ has scored 213 insider transactions for AYTU since Nov 11, 2015. The most recent filing in our index is dated Jul 28, 2026.

Across the full history, 26 open-market purchases and 8 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on AYTU insider trades is 67.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live AYTU trades on FilingIQ Raw filings on SEC EDGAR

Latest AYTU Form 4 filings

Disbrow Joshua R. Chief Executive Officer

P Jun 9, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,070

UNITED THERAPEUTICS Corp

APLS 271

Apellis Pharmaceuticals, Inc.

NUVL 202

Nuvalent, Inc.

KYMR 200

Kymera Therapeutics, Inc.

HNGE 192

Hinge Health, Inc.

GH 189

Guardant Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for AYTU?: FilingIQ tracks 213 Form 4 insider transactions for AYTU (AYTU BIOPHARMA, INC), covering filings from Nov 11, 2015 onwards. 8 of those were filed in the last 90 days.
Are AYTU insiders net buyers or net sellers?: Across the full Form 4 history for AYTU, 26 transactions (12%) were open-market purchases and 8 (4%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does AYTU insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is AYTU in?: AYTU BIOPHARMA, INC (AYTU) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $23.61M.

Methodology & sources

Every AYTU insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.